Substance Withdrawal Monitoring

Withdrawal monitoring is a safety problem, not simply a symptom checklist. Repeated opioid exposure produces physical adaptation. When opioid stimulation falls, withdrawal can produce autonomic, gastrointestinal, pain, and psychological symptoms. The nurse must first determine whether the observed pattern is consistent with withdrawal, opioid toxicity, or abrupt precipitated withdrawal after buprenorphine. The clinical focus here is opioid withdrawal and medications for opioid use disorder. Alcohol and sedative-hypnotic withdrawal require different surveillance and treatment protocols. Opioid use disorder is diagnosed through a clinical assessment by an authorized clinician; a positive urine drug result alone does not establish the diagnosis. The RPN's bedside work is to obtain an accurate substance-and-medication timeline, trend respiratory and withdrawal findings, administer medications within orders and provincial scope, recognize deterioration, and notify the physician or nurse practitioner without delay or activate the rapid response or code team immediately when emergency signs are present. Withdrawal management alone is not recommended; current Canadian guidance calls for continuing addiction treatment because withdrawal alone is associated with relapse, morbidity, and mortality.